From patent to patient: analysing access to innovative cancer drugs
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference29 articles.
1. Exploiting the cancer genome: strategies for the discovery and clinical development of targeted molecular therapeutics;Yap;Annu. Rev. Pharmacol. Toxicol.,2012
2. Cancer treatment in the genomic era;Doherty;Annu. Rev. Biochem.,2019
3. Combinatorial drug therapy for cancer in the post-genomic era;Al-Lazikani;Nat. Biotechnol.,2012
4. Cancer drug resistance: an evolving paradigm;Holohan;Nat. Rev. Cancer,2013
5. Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer;Clarke;Oncogene,2019
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeted protein degrader development for cancer: advances, challenges, and opportunities;Trends in Pharmacological Sciences;2023-05
2. Polymeric Nanocarriers in Cancer Theranostics;Cancer Nanotechnology;2022-12-14
3. Scalable preparation of MOFs and MOF-containing hybrid materials for use in sustainable refrigeration systems for a greener environment: a comprehensive review as well as technical and statistical analysis of patents;Research on Chemical Intermediates;2022-06-17
4. Enhancing access to innovative cancer drugs: Cross-sector consensus on a way forward to benefit patients;Drug Discovery Today;2021-12
5. Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development;Nature Reviews Clinical Oncology;2021-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3